Matthew Donley
Geschäftsführer bei AURINIA PHARMACEUTICALS INC.
Vermögen: 823 602 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Matthew Donley
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
77
| Subsidiary | Biotechnology | 77 |
| Public Company | Biotechnology | 33 | |
| Subsidiary | Pharmaceuticals: Major | 29 | |
| Private Company | Specialty Stores | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Matthew Donley
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | President Private Equity Investor Founder President Private Equity Investor Corporate Officer/Principal | |
| NOVAVAX, INC. | Biotechnology | Director/Board Member Chairman President Director of Finance/CFO Public Communications Contact | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | General Counsel Chairman Public Communications Contact General Counsel | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chairman Director/Board Member | |
| GENVEC INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chairman | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| University of Alberta | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Iowa | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Sales & Marketing | |
| The Johns Hopkins University | College/University | Director/Board Member Graduate Degree Graduate Degree | |
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Operating Officer | |
| VIELA BIO, INC. | Biotechnology | President Chief Executive Officer Director/Board Member | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Public Communications Contact General Counsel Chief Tech/Sci/R&D Officer | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal General Counsel | |
| University of Maryland | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Sales & Marketing Sales & Marketing | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| XENCOR, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| The Leonard N Stern School of Business | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| West Virginia University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | President Sales & Marketing | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of British Columbia | College/University | Corporate Officer/Principal Graduate Degree | |
| MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| ANTARES PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Administrative Officer General Counsel | |
Madison Vaccines, Inc.
 Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Chairman Founder | |
| TESARO INC | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Sucampo GmbH
 Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO |
Statistik
International
| Vereinigte Staaten | 41 |
| Kanada | 7 |
| Vereinigtes Königreich | 4 |
| Schweiz | 2 |
Sektoral
| Health Technology | 34 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Finance | 2 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 477 |
| Corporate Officer/Principal | 242 |
| Independent Dir/Board Member | 152 |
| President | 89 |
| Chairman | 89 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| David Mott | 45 |
| John Johnson | 40 |
| Timothy Walbert | 40 |
| James Cavanaugh | 38 |
| Peter Greenleaf | 31 |
| Robert Spiegel | 30 |
| Karen Smith | 29 |
| Michael Hayden | 27 |
| Paul Edick | 27 |
| R. MacKay-Dunn | 26 |
| Peter Kiener | 25 |
| George Milne | 24 |
| Maureen O'Connell | 24 |
| Melvin Booth | 23 |
| Wayne T. Hockmeyer | 22 |
- Börse
- Insiders
- Matthew Donley
- Unternehmensverbindungen
